» Articles » PMID: 13022874

Antituberculous Immunity Induced in Mice by Vaccination with Living Cultures of Attenuated Tubercle Bacilli

Overview
Journal J Exp Med
Date 1953 Feb 1
PMID 13022874
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The immunity induced in mice by vaccination with living attenuated cultures of tubercle bacilli was measured by two criteria. (a) Increase in survival time of the vaccinated animals after infection with a dose of virulent bacilli sufficient to kill all the unvaccinated controls within 10 to 20 days. (b) Difference in the number of living bacilli recovered from the spleen and lungs of vaccinated and normal animals infected with a small dose of virulent bacilli. The level of immunity induced was found to depend upon the extent of multiplication in vivo of the bacilli used for vaccination. This in turn was conditioned by the degree of attenuation characteristic of the bacterial strain used in the preparation of the vaccine, the amount of vaccine injected, the route of vaccination, and the time interval between vaccination and challenge infection. It was possible to prevent or retard the development of immunity by treating the mice in course of immunization with a drug, isoniazid, capable of interrupting the multiplication in vivo of the bacilli used as vaccine. Although immunity regularly developed and lasted for many weeks when the proper conditions of vaccination were used, the immune response was never sufficient to protect the animals against ultimate death from infection with virulent tubercle bacilli. The prolongation of life in the vaccinated mice was not consequent on a direct bactericidal effect but rather on a retarded or interrupted multiplication of the virulent bacilli in vivo. The quantitative bacteriological techniques used in the present study would appear to be of value for the analysis of certain problems of immunity, and for the appraisal of vaccines and techniques of vaccination.

Citing Articles

Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

SALVIN S, Youngner J, Lederer W Infect Immun. 1973; 7(1):68-75.

PMID: 16558073 PMC: 422640. DOI: 10.1128/iai.7.1.68-75.1973.


BCG OVERDOSAGE TREATED WITH ISONIAZID.

Griffith A Postgrad Med J. 1964; 40:78-80.

PMID: 14129102 PMC: 2482581. DOI: 10.1136/pgmj.40.460.78.


Pathogenicity and immunogenicity of streptomycin-dependent mutants of Brucella.

Simon E, BERMAN D J Bacteriol. 1962; 83:1347-55.

PMID: 13913089 PMC: 279459. DOI: 10.1128/jb.83.6.1347-1355.1962.


Resistance to reinfection in experimental mouse typhoid.

Hobson D J Hyg (Lond). 1957; 55(3):334-43.

PMID: 13475778 PMC: 2217962. DOI: 10.1017/s0022172400037244.


Antituberculous immunity induced by methanol extracts of tubercle bacilli; its enhancement by adjuvants.

Weiss D, DUBOS R J Exp Med. 1956; 103(1):73-85.

PMID: 13278456 PMC: 2136558. DOI: 10.1084/jem.103.1.73.


References
1.
SIEBENMANN C . Effect of BCG vaccination and chemotherapy on experimental tuberculosis in mice. J Immunol. 1951; 67(2):137-49. View

2.
Pierce C, DUBOS R, SCHAEFER W . Multiplication and survival of tubercle bacilli in the organs of mice. J Exp Med. 1953; 97(2):189-206. PMC: 2136194. DOI: 10.1084/jem.97.2.189. View

3.
DUBOS R, SCHAEFER W, Pierce C . Antituberculous immunity in mice vaccinated with killed tubercle bacilli. J Exp Med. 1953; 97(2):221-33. PMC: 2136197. DOI: 10.1084/jem.97.2.221. View